Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | PDE3B | Q13370 | 1/20 | 0.50 |
| ▸ | PDE3A | Q14432 | 1/20 | 0.50 |
| ▸ | CA12 | O43570 | 5/20 | 0.47 |
| ▸ | CA9 | Q16790 | 5/20 | 0.47 |
| ▸ | CA1 | P00915 | 3/20 | 0.47 |
| ▸ | CA2 | P00918 | 3/20 | 0.47 |
| ▸ | CA3 | P07451 | 2/20 | 0.47 |
| ▸ | CA4 | P22748 | 2/20 | 0.47 |
| ▸ | CA6 | P23280 | 2/20 | 0.47 |
| ▸ | CA5A | P35218 | 2/20 | 0.47 |
| ▸ | CA7 | P43166 | 2/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 2/20 | 0.47 |
| ▸ | CA5B | Q9Y2D0 | 2/20 | 0.47 |
| ▸ | LMNA | P02545 | 1/20 | 0.47 |
| ▸ | MCL1 | Q07820 | 1/20 | 0.47 |
| ▸ | SOST | Q9BQB4 | 1/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 4/20 | 0.41 |
| ▸ | HPGD | P15428 | 3/20 | 0.41 |
| ▸ | AKR1B1 | P15121 | 2/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL30030322 | 0.98 | PDE3B (0.51) | PDE3BPDE3ACA12CA9CA1 | |
| SCHEMBL6938 | 0.98 | PDE3B (0.51) | PDE3BPDE3ACA12CA9CA1 | |
| Hydrochloric Acid SCHEMBL7394595 | 0.96 | PDE3B (0.50) | PDE3BPDE3ACA12CA9CA1 | |
| SCHEMBL3829460 | 0.81 | PDE3B (0.42) | PDE3BPDE3ACA12CA9CA1 | |
| Benzimidazole SCHEMBL28458507 | 0.79 | RAB9A (0.49) | PDE3BPDE3ACA12CA9SMN1; SMN2 | |
| SCHEMBL553001 | 0.72 | CA12 (0.48) | CA12CA9CA1CA2CA3 | |
| SCHEMBL542111 | 0.71 | PDE3B (0.58) | PDE3BPDE3ACA12CA9CA1 | |
| SCHEMBL3922666 | 0.71 | PDE3B (0.58) | PDE3BPDE3ACA12CA9CA1 | |
| SCHEMBL10926839 | 0.71 | CA9 (0.56) | PDE3BPDE3ACA12CA9CA1 | |
| SCHEMBL2474491 | 0.71 | PDE3B (0.50) | PDE3BPDE3ACA12CA9SMN1; SMN2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1314755-B1 | Ultraviolet radiation absorbents for thermoplastic polymers and methods of producing the same | TAKEMOTO OIL & FAT CO LTD (JP) | 2010-09-08 | — | — | EP | disclosed |
| EP-1438352-B1 | LOW COLOR, LOW SODIUM BENZOXAZINONE UV ABSORBERS AND PROCESS FOR MAKING SAME | CYTEC TECH CORP (US) | 2010-05-26 | — | — | EP | disclosed |
| US-6774232-B2 | FOR USE IN HIGH TRANSPARENCY APPLICATIONS; TO PREVENT DEGRADATION CAUSED BY SUNLIGHT AND OTHER SOURCES OF ULTRAVIOLET (UV) RADIATION OF POLYMERIC MATERIALS | CYTEC TECHNOLOGY CORP. | 2004-08-10 | — | — | US | disclosed |
| US-6774232-B2 | FOR USE IN HIGH TRANSPARENCY APPLICATIONS; TO PREVENT DEGRADATION CAUSED BY SUNLIGHT AND OTHER SOURCES OF ULTRAVIOLET (UV) RADIATION OF POLYMERIC MATERIALS | CYTEC TECHNOLOGY CORP. | 2004-08-10 | — | — | US | disclosed |
| EP-1438352-A1 | LOW COLOR, LOW SODIUM BENZOXAZINONE UV ABSORBERS AND PROCESS FOR MAKING SAME | Cytec Technology Corp. (US) | 2004-07-21 | — | — | EP | disclosed |
| US-20030096889-A1 | Low color, low sodium benzoxazinone UV absorbers and process for making same | CYTEC TECHNOLOGY CORP. | 2003-05-22 | — | — | US | disclosed |
| US-20030096889-A1 | Low color, low sodium benzoxazinone UV absorbers and process for making same | CYTEC TECHNOLOGY CORP. | 2003-05-22 | — | — | US | disclosed |
| WO-2003035735-A1 | LOW COLOR, LOW SODIUM BENZOXAZINONE UV ABSORBERS AND PROCESS FOR MAKING SAME | CYTEC TECHNOLOGY CORP. (US) | 2003-05-01 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030096889-A1 | Low color, low sodium benzoxazinone UV absorbers and process for making same | XDH, SI, CA4 | PDE3B 2491/4885PDE3A 2341/4885CA12 29/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.